497 related articles for article (PubMed ID: 15731051)
1. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.
Philipovskiy AV; Cowan C; Wulff-Strobel CR; Burnett SH; Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
Infect Immun; 2005 Mar; 73(3):1532-42. PubMed ID: 15731051
[TBL] [Abstract][Full Text] [Related]
2. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.
Cowan C; Philipovskiy AV; Wulff-Strobel CR; Ye Z; Straley SC
Infect Immun; 2005 Sep; 73(9):6127-37. PubMed ID: 16113334
[TBL] [Abstract][Full Text] [Related]
3. Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV.
Ivanov MI; Hill J; Bliska JB
Clin Vaccine Immunol; 2014 May; 21(5):667-73. PubMed ID: 24599533
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.
Miller NC; Quenee LE; Elli D; Ciletti NA; Schneewind O
Infect Immun; 2012 Apr; 80(4):1572-82. PubMed ID: 22252870
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
6. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
[TBL] [Abstract][Full Text] [Related]
7. Virulence role of V antigen of Yersinia pestis at the bacterial surface.
Fields KA; Nilles ML; Cowan C; Straley SC
Infect Immun; 1999 Oct; 67(10):5395-408. PubMed ID: 10496922
[TBL] [Abstract][Full Text] [Related]
8. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.
Noel BL; Lilo S; Capurso D; Hill J; Bliska JB
Clin Vaccine Immunol; 2009 Oct; 16(10):1457-66. PubMed ID: 19710295
[TBL] [Abstract][Full Text] [Related]
9. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG.
Nilles ML; Fields KA; Straley SC
J Bacteriol; 1998 Jul; 180(13):3410-20. PubMed ID: 9642196
[TBL] [Abstract][Full Text] [Related]
10. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
Leary SE; Griffin KF; Galyov EE; Hewer J; Williamson ED; Holmström A; Forsberg A; Titball RW
Microb Pathog; 1999 Mar; 26(3):159-69. PubMed ID: 10089156
[TBL] [Abstract][Full Text] [Related]
11. Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.
Weeks S; Hill J; Friedlander A; Welkos S
Microb Pathog; 2002 May; 32(5):227-37. PubMed ID: 12071679
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis.
Pouliot K; Pan N; Wang S; Lu S; Lien E; Goguen JD
Infect Immun; 2007 Jul; 75(7):3571-80. PubMed ID: 17438030
[TBL] [Abstract][Full Text] [Related]
13. A Recombinant Attenuated
Singh AK; Curtiss R; Sun W
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
[TBL] [Abstract][Full Text] [Related]
14. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis.
Reithmeier-Rost D; Hill J; Elvin SJ; Williamson D; Dittmann S; Schmid A; Wilharm G; Sing A
Microbes Infect; 2007 Jul; 9(8):997-1002. PubMed ID: 17556003
[TBL] [Abstract][Full Text] [Related]
15. Glutathionylation of
Mitchell A; Tam C; Elli D; Charlton T; Osei-Owusu P; Fazlollahi F; Faull KF; Schneewind O
mBio; 2017 May; 8(3):. PubMed ID: 28512097
[TBL] [Abstract][Full Text] [Related]
16. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
[TBL] [Abstract][Full Text] [Related]
17. Yersinia pestis YadC: a novel vaccine candidate against plague.
Murphy BS; Wulff CR; Garvy BA; Straley SC
Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
[TBL] [Abstract][Full Text] [Related]
18. Characterization of outer membrane proteins of Yersinia pestis and Yersinia pseudotuberculosis strains isolated from India.
Khushiramani R; Tuteja U; Shukla J; Batra HV
Indian J Exp Biol; 2004 May; 42(5):508-14. PubMed ID: 15233478
[TBL] [Abstract][Full Text] [Related]
19. N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection.
Hill J; Leary S; Smither S; Best A; Pettersson J; Forsberg A; Lingard B; Lipka A; Brown KA; Williamson ED; Titball RW
Vaccine; 2009 Nov; 27(50):7073-9. PubMed ID: 19786138
[TBL] [Abstract][Full Text] [Related]
20. Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague.
Eisele NA; Anderson DM
Clin Vaccine Immunol; 2009 Dec; 16(12):1720-7. PubMed ID: 19828767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
